Compare Celsius Holdings, Inc. (CELH) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Celsius Holdings, Inc. vs Zimmer Biomet Holdings Inc — how do they compare? Celsius Holdings, Inc. trades at $28.1 (market cap $7.11B), while Zimmer Biomet Holdings Inc trades at $97.27 (market cap $18.55B). The key difference: Zimmer Biomet Holdings Inc is far larger — about 2.6× Celsius Holdings, Inc.'s market cap, and Zimmer Biomet Holdings Inc pays a 0.99% dividend while Celsius Holdings, Inc. pays none. Which is the better fit depends on your goals.
| CELH | ZBH | |
|---|---|---|
Market Cap | $7.11B | $18.55B |
Sector | Consumer Staples | Health |
52-Week High | $64.86 | $107.71 |
52-Week Low | $23.77 | $79.58 |
Enterprise Value | $8.90B | $25.61B |
Dividend Yield | — | 0.99% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Celsius Holdings, Inc.
Celsius Holdings Inc engages in the development, marketing, sale, and distribution of functional calorie-burning beverages. It offers flavors including cola, orange, wild berry and lemon iced tea and non-carbonated flavors such as Raspberry Acai Green Tea and Peach Mango Green Tea under the Celsius brand name. The company distributes its products through direct-store-delivery distributors, as well as directly to retailers across various retail segments, including supermarkets, convenience stores, drug stores, nutritional stores, mass merchants, health clubs, spas, gyms, military, and e-commerce websites.
Read more on CELH →About Zimmer Biomet Holdings Inc
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →
